Post-marketing requirements (PMR) for this BLA included the establishment and qualification of a Working Cell Bank (WCB) to ensure consistent production quality. 2. Technical & Hardware: Linear Technology DC1255A
It is typically administered in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA). 125516
The case involved an irregular LDPC (Low-Density Parity-Check) code . Post-marketing requirements (PMR) for this BLA included the